These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35893694)

  • 1. Influenza Viruses Suitable for Studies in Syrian Hamsters.
    Fan S; Gu C; Kong H; Guan L; Neumann G; Kawaoka Y
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The M segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, filamentous morphology, and efficient contact transmissibility to A/Puerto Rico/8/1934-based reassortant viruses.
    Campbell PJ; Danzy S; Kyriakis CS; Deymier MJ; Lowen AC; Steel J
    J Virol; 2014 Apr; 88(7):3802-14. PubMed ID: 24429367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness.
    Pappas C; Matsuoka Y; Swayne DE; Donis RO
    Clin Vaccine Immunol; 2007 Nov; 14(11):1425-32. PubMed ID: 17913860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity and transmissibility of North American triple reassortant swine influenza A viruses in ferrets.
    Barman S; Krylov PS; Fabrizio TP; Franks J; Turner JC; Seiler P; Wang D; Rehg JE; Erickson GA; Gramer M; Webster RG; Webby RJ
    PLoS Pathog; 2012; 8(7):e1002791. PubMed ID: 22829764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
    Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High-yield reassortant virus containing hemagglutinin and neuraminidase genes of pandemic influenza A/Moscowl/01/2009 (H1N1) virus].
    Ignat'eva AV; Rudneva IA; Timofeeva TA; Shilov AA; Zaberezhnyĭ AD; Aliper TI; Kaverin NV; L'vov DK
    Vopr Virusol; 2011; 56(4):9-14. PubMed ID: 21899062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity and transmissibility of novel reassortant H3N2 influenza viruses with 2009 pandemic H1N1 genes in pigs.
    Ma J; Shen H; Liu Q; Bawa B; Qi W; Duff M; Lang Y; Lee J; Yu H; Bai J; Tong G; Hesse RA; Richt JA; Ma W
    J Virol; 2015 Mar; 89(5):2831-41. PubMed ID: 25540372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composition of hemagglutinin and neuraminidase affects the antigen yield of influenza A(H1N1)pdm09 candidate vaccine viruses.
    Shirakura M; Kawaguchi A; Tashiro M; Nobusawa E
    Jpn J Infect Dis; 2013; 66(1):65-8. PubMed ID: 23429089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    Li X; Gao Y; Ye Z
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segment 2 from influenza A(H1N1) 2009 pandemic viruses confers temperature-sensitive haemagglutinin yield on candidate vaccine virus growth in eggs that can be epistatically complemented by PB2 701D.
    Hussain S; Turnbull ML; Pinto RM; McCauley JW; Engelhardt OG; Digard P
    J Gen Virol; 2019 Jul; 100(7):1079-1092. PubMed ID: 31169484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gene constellation and postreassortment amino acid change on the phenotypic features of H5 influenza virus reassortants.
    Rudneva IA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Varich NL; Ilyushina NA; Gambaryan AS; Krylov PS; Kaverin NV
    Arch Virol; 2007; 152(6):1139-45. PubMed ID: 17294090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone.
    Medina J; Boukhebza H; De Saint Jean A; Sodoyer R; Legastelois I; Moste C
    Vaccine; 2015 Aug; 33(35):4221-7. PubMed ID: 26206270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syrian Hamster as an Animal Model for the Study of Human Influenza Virus Infection.
    Iwatsuki-Horimoto K; Nakajima N; Ichiko Y; Sakai-Tagawa Y; Noda T; Hasegawa H; Kawaoka Y
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virus.
    Zhang Y; Zhang Q; Gao Y; He X; Kong H; Jiang Y; Guan Y; Xia X; Shu Y; Kawaoka Y; Bu Z; Chen H
    J Virol; 2012 Sep; 86(18):9666-74. PubMed ID: 22740390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets.
    Broadbent AJ; Santos CP; Anafu A; Wimmer E; Mueller S; Subbarao K
    Vaccine; 2016 Jan; 34(4):563-570. PubMed ID: 26655630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets.
    Imai M; Watanabe T; Hatta M; Das SC; Ozawa M; Shinya K; Zhong G; Hanson A; Katsura H; Watanabe S; Li C; Kawakami E; Yamada S; Kiso M; Suzuki Y; Maher EA; Neumann G; Kawaoka Y
    Nature; 2012 May; 486(7403):420-8. PubMed ID: 22722205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of a bivalent inactivated reassortant H1N1 influenza virus vaccine against European avian-like and classical swine influenza H1N1 viruses in mice.
    Ruan BY; Yao Y; Wang SY; Gong XQ; Liu XM; Wang Q; Yu LX; Zhu SQ; Wang J; Shan TL; Zhou YJ; Tong W; Zheng H; Li GX; Gao F; Kong N; Yu H; Tong GZ
    Vet Microbiol; 2020 Jul; 246():108724. PubMed ID: 32605742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Egg-adaptive mutations in H3N2v vaccine virus enhance egg-based production without loss of antigenicity or immunogenicity.
    Barman S; Franks J; Turner JC; Yoon SW; Webster RG; Webby RJ
    Vaccine; 2015 Jun; 33(28):3186-92. PubMed ID: 25999284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content.
    Abt M; de Jonge J; Laue M; Wolff T
    Vaccine; 2011 Jul; 29(32):5153-62. PubMed ID: 21624413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs.
    Ruan BY; Wen F; Gong XQ; Liu XM; Wang Q; Yu LX; Wang SY; Zhang P; Yang HM; Shan TL; Zheng H; Zhou YJ; Tong W; Gao F; Tong GZ; Yu H
    Vet Microbiol; 2018 Aug; 222():75-84. PubMed ID: 30080677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.